ATPase, Na+/K+ transporting, alpha 1

Sodium/potassium-transporting ATPase subunit alpha-1 is an enzyme that in humans is encoded by the ATP1A1 gene.[5]

ATP1A1
Identifiers
AliasesATP1A1, ATPase, Na+/K+ transporting, alpha 1, ATPase Na+/K+ transporting subunit alpha 1, CMT2DD, HOMGSMR2
External IDsOMIM: 182310 MGI: 88105 HomoloGene: 564 GeneCards: ATP1A1
Gene location (Human)
Chr.Chromosome 1 (human)[1]
Band1p13.1Start116,372,668 bp[1]
End116,410,261 bp[1]
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

476

11928

Ensembl

ENSG00000163399

ENSMUSG00000033161

UniProt

P05023
Q5TC02

Q8VDN2

RefSeq (mRNA)

NM_000701
NM_001001586
NM_001160233
NM_001160234

NM_144900

RefSeq (protein)

NP_000692
NP_001153705
NP_001153706

NP_659149

Location (UCSC)Chr 1: 116.37 – 116.41 MbChr 3: 101.58 – 101.6 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
Gastric H+/K+-ATPase, N terminal domain
tfe-induded structure of the n-terminal domain of pig gastric h/k-atpase
Identifiers
SymbolH-K_ATPase_N
PfamPF09040
InterProIPR015127

The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of Na+/K+-ATPases. Na+/K+-ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These gradients are essential for osmoregulation, for sodium-coupled transport of a variety of organic and inorganic molecules, and for electrical excitability of nerve and muscle. This enzyme is composed of two subunits, a large catalytic subunit (alpha) and a smaller glycoprotein subunit (beta). The catalytic subunit of Na+/K+-ATPase is encoded by multiple genes. This gene encodes an alpha 1 subunit. Alternatively spliced transcript variants encoding different isoforms have been identified.[5]

In melanocytic cells ATP1A1 gene expression may be regulated by MITF.[6]

Clinical relevance

Mutations in this gene have been associated with aldosterone-producing adenomas and secondary hypertension.[7]

References

  1. GRCh38: Ensembl release 89: ENSG00000163399 - Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000033161 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. "Entrez Gene: ATP1A1 ATPase, Na+/K+ transporting, alpha 1 polypeptide".
  6. Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, Valgeirsdottir S, Bergsteinsdottir K, Schepsky A, Dummer R, Steingrimsson E (December 2008). "Novel MITF targets identified using a two-step DNA microarray strategy". Pigment Cell & Melanoma Research. 21 (6): 665–76. doi:10.1111/j.1755-148X.2008.00505.x. PMID 19067971.
  7. Beuschlein F, Boulkroun S, Osswald A, Wieland T, Nielsen HN, Lichtenauer UD, Penton D, Schack VR, Amar L, Fischer E, Walther A, Tauber P, Schwarzmayr T, Diener S, Graf E, Allolio B, Samson-Couterie B, Benecke A, Quinkler M, Fallo F, Plouin PF, Mantero F, Meitinger T, Mulatero P, Jeunemaitre X, Warth R, Vilsen B, Zennaro MC, Strom TM, Reincke M (April 2013). "Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension". Nature Genetics. 45 (4): 440–4, 444e1–2. doi:10.1038/ng.2550. PMID 23416519.

Further reading


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.